These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4177178)

  • 1. Hypercalcaemia from calcium resin.
    Bone JM; Davison AM
    Lancet; 1968 Nov; 2(7578):1137. PubMed ID: 4177178
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcaemia from calcium ion-exchange resin in patients on regular haemodialysis.
    Papadimitriou M; Gingell JC; Chisholm GD
    Lancet; 1968 Nov; 2(7575):948-50. PubMed ID: 4176266
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypercalcaemia from calcium resin in patients with chronic renal failure.
    Sevitt LH; Wrong OM
    Lancet; 1968 Nov; 2(7575):950-1. PubMed ID: 4176267
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcemia in 25 OH D3 treated patients receiving a calcium exchange resin.
    Labeeuw M; Cabanne JF
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):316-9. PubMed ID: 4018932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcaemia from calcium resin.
    Knapp MS; Heath DA
    Lancet; 1968 Nov; 2(7578):1136-7. PubMed ID: 4177177
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercalcaemia from calcium resin.
    Swales JD; Sevitt LH; Wrong OM
    Lancet; 1969 Mar; 1(7593):532. PubMed ID: 4179606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypercalcemic crises in patients with chronic kidney failure due to calcium-containing ion-exchangers, antacids and other drugs].
    Graben N; Cremer W; Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1505-8. PubMed ID: 1030032
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypercalcaemic crises in patients with chronic renal failure caused by ion-exchange resins, antacidotics and other calcium-containing drugs (author's transl)].
    Graben N; Cremer W; Anlauf M; Bock KD
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1903-7. PubMed ID: 598299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle).
    Frohnert PP; Johnson WJ; Mueller GJ; Tauxe WN; McCall JT
    J Lab Clin Med; 1968 May; 71(5):840-6. PubMed ID: 5647685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with ion exhcange resins in the calcium phase during the management of hyperkalemia].
    Ritz E; Fanz HE; Herzfeld G
    Dtsch Med Wochenschr; 1969 Jan; 94(2):75-7. PubMed ID: 5782694
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic renal disease progression: treatment strategies and potassium intake.
    Sinha AD; Agarwal R
    Semin Nephrol; 2013 May; 33(3):290-9. PubMed ID: 23953806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diet therapy of renal insufficiency].
    Kluthe R; Quirin H
    Dtsch Med Wochenschr; 1969 Oct; 94(41):2112-4. PubMed ID: 5811278
    [No Abstract]   [Full Text] [Related]  

  • 13. Cation exchange resins in hyperkalaemic renal failure.
    Berlyne GM; Shaw AB
    Isr J Med Sci; 1967; 3(1):45-52. PubMed ID: 6047691
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperkalemia in dialysis patients.
    Ahmed J; Weisberg LS
    Semin Dial; 2001; 14(5):348-56. PubMed ID: 11679104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperkalemia].
    Le Gall JR
    Nouv Presse Med; 1974 May; 3(21):1391-2. PubMed ID: 4848890
    [No Abstract]   [Full Text] [Related]  

  • 16. [Special low-protein diets in treatment of chronic renal failure].
    Poleć R; Kociszewski J
    Wiad Lek; 1971 Sep; 24(17):1629-33. PubMed ID: 4940362
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients.
    Johnson K; Cazee C; Gutch C; Ogden D
    Clin Nephrol; 1976 Jun; 5(6):266-8. PubMed ID: 1277599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium.
    Rachoin JS; Weisberg LS
    Semin Dial; 2008; 21(3):223-5. PubMed ID: 18363596
    [No Abstract]   [Full Text] [Related]  

  • 19. Dangers of resonium A in the treatment of hyperkalemia in renal failure.
    Berlyne GM; Janabi K; Shaw AB
    Lancet; 1966 Jan; 1(7430):167-9. PubMed ID: 4164887
    [No Abstract]   [Full Text] [Related]  

  • 20. Potassium balance in dialysis patients.
    Sanghavi S; Whiting S; Uribarri J
    Semin Dial; 2013; 26(5):597-603. PubMed ID: 24073843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.